Reply To: Accelerating Phase 1 timelines as much as possible


Bhavin Patel
Participant

Reply To: Accelerating Phase 1 timelines as much as possible

Any thoughts and/or experience regarding this:

If only sending unlabeled brite stock to clinical site and site labels it clinically, what has been the experience on TMF filing requirements from sponsor perspective and related to regulations?